Takeda Pharmaceutical Company Limited
HETEROCYCLIC COMPOUND AND USE THEREOF
Last updated:
Abstract:
The present invention provides a heterocyclic compound having an orexin type 2 receptor agonist activity. A compound represented by the formula (I): ##STR00001## wherein each symbol is as described in the specification, or a salt thereof, is useful as an agent for the prophylaxis or treatment of narcolepsy.
Status:
Application
Type:
Utility
Filling date:
20 Sep 2019
Issue date:
16 Jan 2020